Year |
Citation |
Score |
2006 |
Pressley JS, Elgert KD. Post-chemotherapeutic administration of interleukin-12 retards tumor growth and enhances immune cell function: combination therapy using paclitaxel and IL-12. Cancer Investigation. 24: 351-9. PMID 16777686 DOI: 10.1080/07357900600705276 |
0.459 |
|
2003 |
Mullins DW, Martins RS, Elgert KD. Tumor-derived cytokines dysregulate macrophage interferon-gamma responsiveness and interferon regulatory factor-8 expression. Experimental Biology and Medicine (Maywood, N.J.). 228: 270-7. PMID 12626771 DOI: 10.1177/153537020322800305 |
0.725 |
|
2001 |
Mullins DW, Martins RS, Burger CJ, Elgert KD. Tumor cell-derived TGF-beta and IL-10 dysregulate paclitaxel-induced macrophage activation. Journal of Leukocyte Biology. 69: 129-37. PMID 11200057 |
0.698 |
|
2001 |
Mullins DW, Martins RS, Burger CJ, Elgert KD. Tumor cell-derived TGF-β and IL-10 dysregulate paclitaxel-induced macrophage activation Journal of Leukocyte Biology. 69: 129-137. DOI: 10.1189/Jlb.69.1.129 |
0.726 |
|
1999 |
Mullins DW, Burger CJ, Elgert KD. Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide. Journal of Immunology (Baltimore, Md. : 1950). 162: 6811-8. PMID 10352302 |
0.679 |
|
1998 |
Mullins DW, Burger CJ, Elgert KD. Tumor growth modulates macrophage nitric oxide production following paclitaxel administration. International Journal of Immunopharmacology. 20: 537-51. PMID 9839658 DOI: 10.1016/S0192-0561(98)00047-2 |
0.721 |
|
1998 |
Mullins DW, Koci MD, Burger CJ, Elgert KD. Interleukin-12 overcomes paclitaxel-mediated suppression of T-cell proliferation. Immunopharmacology and Immunotoxicology. 20: 473-92. PMID 9805229 DOI: 10.3109/08923979809031511 |
0.74 |
|
1998 |
Elgert KD, Alleva DG, Mullins DW. Tumor-induced immune dysfunction: the macrophage connection. Journal of Leukocyte Biology. 64: 275-90. PMID 9738653 DOI: 10.1002/Jlb.64.3.275 |
0.734 |
|
1997 |
Mullins DW, Walker TM, Burger CJ, Elgert KD. Taxol-mediated changes in fibrosarcoma-induced immune cell function: modulation of antitumor activities. Cancer Immunology, Immunotherapy : Cii. 45: 20-8. PMID 9353423 DOI: 10.1007/S002620050396 |
0.755 |
|
1997 |
Mullins DW, Alleva DG, Burger CJ, Elgert KD. Taxol, a microtubule-stabilizing antineoplastic agent, differentially regulates normal and tumor-bearing host macrophage nitric oxide production. Immunopharmacology. 37: 63-73. PMID 9285245 DOI: 10.1016/S0162-3109(97)00004-0 |
0.735 |
|
1995 |
Alleva DG, Askew D, Burger CJ, Elgert KD. Macrophage priming and activation during fibrosarcoma growth: expression of c-myb, c-myc, c-fos, and c-fms. Immunological Investigations. 23: 457-72. PMID 7851963 DOI: 10.3109/08820139409066840 |
0.387 |
|
1995 |
Alleva DG, Walker TM, Elgert KD. Induction of macrophage suppressor activity by fibrosarcoma-derived transforming growth factor-beta 1: contrasting effects on resting and activated macrophages. Journal of Leukocyte Biology. 57: 919-28. PMID 7790775 DOI: 10.1002/Jlb.57.6.919 |
0.438 |
|
1995 |
Alleva DG, Elgert KD. Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during tumor growth. Immunobiology. 192: 155-71. PMID 7782092 DOI: 10.1016/S0171-2985(11)80094-X |
0.565 |
|
1994 |
Walker TM, Burger CJ, Elgert KD. Tumor growth alters T cell and macrophage production of and responsiveness to granulocyte-macrophage colony-stimulating factor: partial dysregulation through interleukin-10. Cellular Immunology. 154: 342-57. PMID 8131207 DOI: 10.1006/Cimm.1994.1082 |
0.613 |
|
1994 |
Alleva DG, Burger CJ, Elgert KD. Tumour growth causes suppression of autoreactive T-cell proliferation by disrupting macrophage responsiveness to interferon-gamma. Scandinavian Journal of Immunology. 39: 31-8. PMID 7904773 DOI: 10.1111/J.1365-3083.1994.Tb03336.X |
0.499 |
|
1993 |
Askew D, Burger CJ, Elgert KD. Tumor growth and adherence change the expression of macrophage Mac-2. Cancer Letters. 69: 67-74. PMID 8481895 DOI: 10.1016/0304-3835(93)90034-7 |
0.504 |
|
1993 |
Alleva DG, Burger CJ, Elgert KD. Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity. Journal of Leukocyte Biology. 53: 550-558. PMID 8388910 DOI: 10.1002/Jlb.53.5.550 |
0.532 |
|
1993 |
Alleva DG, Askew D, Burger CJ, Elgert KD. Fibrosarcoma‐induced increase in macrophage tumor necrosis factor α synthesis suppresses T cell responses Journal of Leukocyte Biology. 54: 152-160. PMID 8360594 DOI: 10.1002/Jlb.54.2.152 |
0.571 |
|
1993 |
Alleva DG, Burger CJ, Elgert KD. Interferon-gamma reduces tumor-induced Ia- macrophage-mediated suppression: role of prostaglandin E2, Ia, and tumor necrosis factor-alpha. Immunopharmacology. 25: 215-27. PMID 8354638 DOI: 10.1016/0162-3109(93)90050-Z |
0.5 |
|
1993 |
Askew D, Burger CJ, Elgert KD. Tumor-induced modulation of macrophage class II MHC molecule mRNA expression. Molecular Immunology. 30: 911-20. PMID 8341283 DOI: 10.1016/0161-5890(93)90015-4 |
0.408 |
|
1993 |
Walker TM, Burger CJ, Elgert KD. Tumor growth alters macrophage responsiveness to macrophage colony-stimulating factor during reactivity against allogeneic and syngeneic MHC class II molecules. Immunological Investigations. 22: 463-76. PMID 8262568 DOI: 10.3109/08820139309063424 |
0.486 |
|
1993 |
Alleva DG, Burger CJ, Elgert KD. Tumor-induced macrophage tumor necrosis factor-alpha production suppresses autoreactive T cell proliferation. Immunobiology. 188: 430-45. PMID 8244447 DOI: 10.1016/S0171-2985(11)80225-1 |
0.49 |
|
1993 |
Walker TM, Yurochko AD, Burger CJ, Elgert KD. Ia- macrophages and cytokine networks contribute to tumor-induced suppression of CD4+ autoreactive T cells. Immunological Investigations. 22: 169-87. PMID 8099569 DOI: 10.3109/08820139309063401 |
0.769 |
|
1992 |
Walker TM, Yurochko AD, Burger CJ, Elgert KD. Macrophages stimulated by receptor-ligand interactions exhibit differences in cell-cycle kinetics during tumor growth: stimulation at Mac-1 and Mac-3 receptors alters DNA synthesis. Immunology Letters. 31: 217-25. PMID 1548036 DOI: 10.1016/0165-2478(92)90117-7 |
0.658 |
|
1992 |
Walker TM, Yurochko AD, Burger CJ, Elgert KD. Cytokines and suppressor macrophages cause tumor-bearing host CD8+ T cells to suppress recognition of allogeneic and syngeneic MHC class II molecules. Journal of Leukocyte Biology. 52: 661-9. PMID 1464737 DOI: 10.1002/Jlb.52.6.661 |
0.709 |
|
1992 |
Walker TM, Yurochko AD, Burger CJ, Elgert KD. Tumor growth changes the contribution of granulocyte-macrophage colony-stimulating factor during macrophage-mediated suppression of allorecognition. Immunobiology. 185: 427-39. PMID 1452214 DOI: 10.1016/S0171-2985(11)80085-9 |
0.722 |
|
1991 |
Askew D, Burger CJ, Elgert KD. Modulation of alloreactivity by Mac-1+, -2+, and -3+ macrophages from normal and tumor-bearing hosts: flow cytofluorometrically separated macrophages. Immunobiology. 182: 1-10. PMID 2151512 DOI: 10.1016/S0171-2985(11)80578-4 |
0.45 |
|
1990 |
Yurochko AD, Burger CJ, Elgert KD. Two-color flow cytometric analysis of the expression of MAC and MHC Class II antigens on macrophages during tumor growth Cytometry. 11: 725-735. PMID 2200657 DOI: 10.1002/Cyto.990110610 |
0.72 |
|
1990 |
Yurochko AD, Burger CJ, Elgert KD. Tumor modulation of autoreactivity: Decreased macrophage and autoreactive T cell interactions Cellular Immunology. 127: 105-119. PMID 2138515 DOI: 10.1016/0008-8749(90)90118-B |
0.744 |
|
1990 |
Askew D, Yurochko AD, Burger CJ, Elgert KD. Normal and tumor-bearing host macrophage responses: variability in accessory function, surface markers, and cell-cycle kinetics Immunology Letters. 24: 21-29. PMID 1695610 DOI: 10.1016/0165-2478(90)90031-K |
0.67 |
|
1990 |
Yurochko AD, Askew D, Burger CJ, Elgert KD. Normal and tumor-bearing host splenic macrophage responses to lipopolysaccharide Immunological Investigations. 19: 41-55. PMID 1692569 DOI: 10.3109/08820139009042024 |
0.664 |
|
1989 |
Malick AP, Yurochko AD, Burger CJ, Askew D, Elgert KD. Tumor-induced variations in a high molecular weight inhibitory monokine. Immunobiology. 178: 361-79. PMID 2785483 DOI: 10.1016/S0171-2985(89)80059-2 |
0.736 |
|
1989 |
Yurochko AD, Pyle RH, Elgert KD. Changes in macrophage populations: Phenotypic differences between normal and tumor-bearing host macrophages Immunobiology. 178: 416-435. PMID 2654009 DOI: 10.1016/S0171-2985(89)80063-4 |
0.71 |
|
1989 |
Yurochko AD, Nagarkatti PS, Nagarkatti M, Elgert KD. Tumor-induced alteration in macrophage accessory cell activity on autoreactive T cells Cancer Immunology Immunotherapy. 30: 170-176. PMID 2598186 DOI: 10.1007/Bf01669426 |
0.743 |
|
1987 |
Malick AP, Elgert KD, Garner RE, Adkinson NF. Prostaglandin E2 production by Mac-2+ macrophages: tumor-induced population shift. Journal of Leukocyte Biology. 42: 673-81. PMID 2960767 DOI: 10.1002/Jlb.42.6.673 |
0.488 |
|
1987 |
Garner RE, Malick AP, Yurochko AD, Elgert KD. Shifts in macrophage (M phi) surface phenotypes during tumor growth: association of Mac-2+ and Mac-3+ M phi with immunosuppressive activity. Cellular Immunology. 108: 255-68. PMID 2957065 DOI: 10.1016/0008-8749(87)90211-5 |
0.709 |
|
1986 |
Garner RE, Elgert KD. Changes in splenic macrophage Mac antigen expression during tumor growth: a kinetic study of accessory cell function and antigen-defined phenotypes. Journal of Leukocyte Biology. 40: 709-24. PMID 3537182 DOI: 10.1002/Jlb.40.6.709 |
0.534 |
|
1986 |
Garner RE, Malick AP, Elgert KD. Variations in macrophage antigen phenotype: a correlation between Ia antigen reduction and immune dysfunction during tumor growth. Journal of Leukocyte Biology. 40: 561-74. PMID 3464674 DOI: 10.1002/Jlb.40.5.561 |
0.548 |
|
1986 |
Roberson AM, Elgert KD. Splenocytes from tumor-bearing Corynebacterium parvum treated mice maintain interleukin-2 and -3 activity. Cancer Immunology, Immunotherapy : Cii. 22: 49-55. PMID 2939948 DOI: 10.1007/Bf00205716 |
0.445 |
|
1984 |
Burger CJ, Elgert KD. Interleukin 3 activity in tumor-bearing hosts: decreased splenocyte production of and responsiveness to IL 3. Immunological Communications. 13: 255-68. PMID 6430790 DOI: 10.3109/08820138409025466 |
0.359 |
|
1984 |
Garner RE, Malick AP, Connolly KM, Elgert KD. In vivo assessment of tumor-induced nonspecific suppression of contact sensitivity. II. Regulation by cytokines and T cells via adoptive transfer. Cancer Immunology, Immunotherapy : Cii. 18: 135-7. PMID 6391655 DOI: 10.1007/Bf00205748 |
0.499 |
|
1984 |
Malick AP, Garner RE, Black SP, Elgert KD. Normal and tumor-bearing host macrophage factor-mediated modulation of mixed-lymphocyte reaction responsiveness: separation of T-lymphocyte subset susceptibility to enhancing and inhibitory factors. Cellular Immunology. 85: 549-55. PMID 6232006 DOI: 10.1016/0008-8749(84)90267-3 |
0.554 |
|
1984 |
Burger CJ, Elgert KD, Farrar WL. Interleukin 2 (IL-2) activity during tumor growth: IL-2 production kinetics, absorption of and responses to exogenous IL-2. Cellular Immunology. 84: 228-39. PMID 6231106 DOI: 10.1016/0008-8749(84)90095-9 |
0.631 |
|
1984 |
Denbow CJ, Conroy JM, Elgert KD. Macrophage-derived prostaglandin E modulation of the mixed-lymphocyte reaction: An anomaly of increased production and decreased T-cell susceptibility during tumor growth Cellular Immunology. 84: 1-13. PMID 6230157 DOI: 10.1016/0008-8749(84)90071-6 |
0.54 |
|
1983 |
Burger CJ, Elgert KD. Level of macrophage induction during tumor growth: primed or activated? Immunological Communications. 12: 285-90. PMID 6885106 DOI: 10.3109/08820138309050750 |
0.486 |
|
1983 |
Connolly KM, Elgert KD, Conroy JM, Vogel SN, Rutherford RB. Immunoregulation of the mixed lymphocyte reaction by macrophage-derived factors: functional and biochemical separation of enhancing and inhibitory factors. Immunobiology. 164: 144-59. PMID 6221994 DOI: 10.1016/S0171-2985(83)80006-0 |
0.341 |
|
1982 |
Farrar WL, Elgert KD, Burger CJ. Tumor-induced impairment of T-cell-independent B-cell blastogenesis and DNA polymerase activity. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 169: 127-34. PMID 6461011 DOI: 10.3181/00379727-169-41320 |
0.655 |
|
1981 |
Willard KE, Elgert KD. Glucocorticosteroid modification of lymphocyte blastogenesis in tumor-bearing hosts. Cellular Immunology. 55: 355-65. PMID 6448696 DOI: 10.1016/0008-8749(80)90167-7 |
0.585 |
|
1980 |
Elgert KD. In vivo assessment of tumor-induced nonspecific suppression of contact sensitivity. I. Correlation with in vitro studies. Cellular Immunology. 49: 395-401. PMID 7353215 DOI: 10.1016/0008-8749(80)90042-8 |
0.486 |
|
1980 |
Elgert KD, Connolly KM. Enhancement of T cell MLR reactivity by addition of macrophage supernatants from tumor-bearing mice. Oncology. 37: 101-6. PMID 6444706 DOI: 10.1159/000225414 |
0.582 |
|
1979 |
Farrar WL, Elgert KD. In vitro immune blastogenesis during contact sensitivity in tumor-bearing mice. II. Mechanism of inhibition. Cellular Immunology. 40: 365-75. PMID 309800 DOI: 10.1016/0008-8749(78)90344-1 |
0.696 |
|
1979 |
Elgert KD, Farrar WL. In vitro immune blastogenesis during contact sensitivity in tumor-bearing mice. I. Description of progressive impairment and demonstration of splenic suppressor cells. Cellular Immunology. 40: 356-64. PMID 309799 DOI: 10.1016/0008-8749(78)90343-X |
0.64 |
|
1979 |
Connolly KM, Elgert KD. Regulation of T-cell mixed lymphocyte reaction reactivity: demonstration of enhancing and inhibitory activity in tumor bearing host macrophages supernatants. Cellular Immunology. 45: 94-107. PMID 156588 DOI: 10.1016/0008-8749(79)90365-4 |
0.511 |
|
1979 |
Connolly KM, Elgert KD. Reversal of macrophage-augmented MLR reactivity by tumor-induced splenic suppressor T cells and their soluble factor(s). Cellular Immunology. 44: 99-108. PMID 156587 DOI: 10.1016/0008-8749(79)90031-5 |
0.542 |
|
1979 |
Gebel HM, Barrett JT, Elgert KD, Campbell BJ, Finke JH. Inactivation of Complement by Loxosceles Reclusa Spider Venom The American Journal of Tropical Medicine and Hygiene. 28: 756-762. DOI: 10.4269/ajtmh.1979.28.756 |
0.52 |
|
1979 |
Connolly KM, Farrar WL, Elgert KD. Tumor-Induced Dualistic Suppressor Cell Regulation: Macrophages And Suppressor T Cells Cell Biology and Immunology of Leukocyte Function. 701-705. DOI: 10.1016/B978-0-12-569650-0.50094-2 |
0.687 |
|
1978 |
Farrar WL, Elgert KD. Inhibition of mitogen and immune blastogenesis by two distinct populations of supressor cells present in the spleens of fibrosarcoma-bearing mice: adoptive transfer of suppression. International Journal of Cancer. 22: 142-51. PMID 308934 DOI: 10.1002/Ijc.2910220207 |
0.661 |
|
1978 |
Elgert KD, Connolly KM. Macrophage regulation of the T-cell allogeneic response during tumor growth. Cellular Immunology. 35: 1-14. PMID 145897 DOI: 10.1016/0008-8749(78)90121-1 |
0.597 |
|
1975 |
Elgert KD, Ross MA, Campbell BJ, Barrett JT. Immunological studies of Brown recluse spider venom. Infection and Immunity. 10: 1412-9. PMID 4140161 DOI: 10.1128/Iai.10.6.1412-1419.1974 |
0.545 |
|
1973 |
Wright RP, Elgert KD, Campbell BJ, Barrett JT. Hyaluronidase and esterase activities of the venom of the poisonous brown recluse spider. Archives of Biochemistry and Biophysics. 159: 415-26. PMID 4206202 DOI: 10.1016/0003-9861(73)90469-4 |
0.558 |
|
Show low-probability matches. |